Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucienne Chatenoud

Showing results (41-50 of 138) with videos related to

Pageof 14
Sort By:
Current Opinion in Organ Transplantation|October 6, 2011
Harnessing regulatory T cells for transplant tolerance in the clinic through mTOR inhibition: myth or reality?Julien Zuber, Olivier Hermine, Lucienne Chatenoud, et al.
Diabetes|December 22, 2012
Recent lessons learned from prevention and recent-onset type 1 diabetes immunotherapy trialsTeodora P Staeva, Lucienne Chatenoud, Richard Insel, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 5, 2002
Nonmitogenic CD3 antibody reverses virally induced (rat insulin promoter-lymphocytic choriomeningitis virus) autoimmune diabetes without impeding viral clearanceMatthias G von Herrath, Bryan Coon, Tom Wolfe, et al.
Clinical Immunology (Orlando, Fla.)|June 4, 2013
Anti-CD3 clinical trials in type 1 diabetes mellitusAnastasia G Daifotis, Scott Koenig, Lucienne Chatenoud, et al.
Journal of Autoimmunity|April 15, 2005
G-CSF treatment prevents cyclophosphamide acceleration of autoimmune diabetes in the NOD mouseKarine Hadaya, Hassen Kared, Annie Masson, et al.
Advances in Immunology|December 30, 2008
CD3 antibodies as unique tools to restore self-tolerance in established autoimmunity their mode of action and clinical application in type 1 diabetesSylvaine You, Sophie Candon, Chantal Kuhn, et al.
Cold Spring Harbor Perspectives in Medicine|September 16, 2024
The Teplizumab Saga: The Challenge of Not Getting Lost in Clinical TranslationLucienne Chatenoud, Kevan C Herold, Jean-François Bach, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 2, 2004
Unique role of CD4+CD62L+ regulatory T cells in the control of autoimmune diabetes in T cell receptor transgenic miceSylvaine You, Géraldine Slehoffer, Samia Barriot, et al.
Frontiers in Immunology|February 3, 2016
Inducing and Administering Tregs to Treat Human DiseaseAna Luisa Perdigoto, Lucienne Chatenoud, Jeffrey A Bluestone, et al.
Journal of Pediatric Gastroenterology and Nutrition|September 9, 2011
Monitoring of anti-transglutaminase autoantibodies in pediatric celiac disease using a sensitive radiobinding assaySophie Candon, François-Xavier Mauvais, Hélène Garnier-Lengliné, et al.
Pageof 14

Showing results (41-50 of 138) with videos related to

Sort By:
Pageof 14
Current Opinion in Organ Transplantation|October 6, 2011
Harnessing regulatory T cells for transplant tolerance in the clinic through mTOR inhibition: myth or reality?Julien Zuber, Olivier Hermine, Lucienne Chatenoud, et al.
Diabetes|December 22, 2012
Recent lessons learned from prevention and recent-onset type 1 diabetes immunotherapy trialsTeodora P Staeva, Lucienne Chatenoud, Richard Insel, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 5, 2002
Nonmitogenic CD3 antibody reverses virally induced (rat insulin promoter-lymphocytic choriomeningitis virus) autoimmune diabetes without impeding viral clearanceMatthias G von Herrath, Bryan Coon, Tom Wolfe, et al.
Clinical Immunology (Orlando, Fla.)|June 4, 2013
Anti-CD3 clinical trials in type 1 diabetes mellitusAnastasia G Daifotis, Scott Koenig, Lucienne Chatenoud, et al.
Journal of Autoimmunity|April 15, 2005
G-CSF treatment prevents cyclophosphamide acceleration of autoimmune diabetes in the NOD mouseKarine Hadaya, Hassen Kared, Annie Masson, et al.
Advances in Immunology|December 30, 2008
CD3 antibodies as unique tools to restore self-tolerance in established autoimmunity their mode of action and clinical application in type 1 diabetesSylvaine You, Sophie Candon, Chantal Kuhn, et al.
Cold Spring Harbor Perspectives in Medicine|September 16, 2024
The Teplizumab Saga: The Challenge of Not Getting Lost in Clinical TranslationLucienne Chatenoud, Kevan C Herold, Jean-François Bach, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 2, 2004
Unique role of CD4+CD62L+ regulatory T cells in the control of autoimmune diabetes in T cell receptor transgenic miceSylvaine You, Géraldine Slehoffer, Samia Barriot, et al.
Frontiers in Immunology|February 3, 2016
Inducing and Administering Tregs to Treat Human DiseaseAna Luisa Perdigoto, Lucienne Chatenoud, Jeffrey A Bluestone, et al.
Journal of Pediatric Gastroenterology and Nutrition|September 9, 2011
Monitoring of anti-transglutaminase autoantibodies in pediatric celiac disease using a sensitive radiobinding assaySophie Candon, François-Xavier Mauvais, Hélène Garnier-Lengliné, et al.
Pageof 14